Elisabet Ohlin Sjöström
Visiting researcher at Department of Public Health and Caring Sciences; Molecular Geriatrics / Rudbeck laboratory
- Visiting address:
- Dag Hammarskjölds väg 20
- Postal address:
- Rudbecklaboratoriet
751 85 Uppsala
Short presentation
Post doc researcher working on vascular permeability in the CNS and aspects of blood-brain barrier permeability in disease.
Currently funded as a post doc by SSMF
(http://www.ssmf.se/stipendiater-forskare/elisabet-ohlin)

Publications
Recent publications
-
Part of mAbs, 2024
- DOI for Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
- Download full text (pdf) of Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
-
Part of PLOS ONE, 2022
- DOI for Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels
- Download full text (pdf) of Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels
-
Part of Molecular Cancer Therapeutics, p. 1961-1972, 2018
- DOI for Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity
- Download full text (pdf) of Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity
-
VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
Part of Nature Communications, 2016
- DOI for VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
- Download full text (pdf) of VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
-
Part of Science Signaling, 2016
All publications
Articles in journal
-
Part of mAbs, 2024
- DOI for Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
- Download full text (pdf) of Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
-
Part of PLOS ONE, 2022
- DOI for Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels
- Download full text (pdf) of Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels
-
Part of Molecular Cancer Therapeutics, p. 1961-1972, 2018
- DOI for Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity
- Download full text (pdf) of Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity
-
VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
Part of Nature Communications, 2016
- DOI for VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
- Download full text (pdf) of VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
-
Part of Science Signaling, 2016
-
Part of Science Signaling, 2015
-
Histidine-Rich Glycoprotein (HRG): A Novel Gene-Therapy Effector for the Treatment of Cancer
Part of Molecular Therapy, 2014
-
Histidine-Rich Glycoprotein (HRG): A Novel Gene-Therapy Effector for the Treatment of Cancer
Part of Molecular Therapy, 2013
-
Part of Brain, p. 2339-2357, 2011